Hosted By
Glucagon-Like-Peptide-1 receptor agonists (GLP-1 RA) are a class of medications originally developed to treat type 2 diabetes, but have since gained widespread attention for their effects on weight loss and metabolic health. Emerging research suggests that GLP1-Receptor Agonists could be supportive in managing inflammatory symptoms associated with Mast Cell Activation Syndrome (MCAS). Although research is currently limited, Anna talks about what we know so far and her experience with clients taking these drugs in clinical practice.
Useful Links
Research Paper: https://www.sciencedirect.com/science/article/abs/pii/S0002962925011061
Take the Chronic Fatigue Quiz: https://app.annamarsh.co.uk/quiz-page
Instagram: https://www.instagram.com/anna__marsh_
Work with me: https://annamarsh.co.uk/work-together/
Website: http://annamarsh.co.uk/
Join the Nurturing Resilience Subscription: https://annamarsh.co.uk/nurturing-resilience/
Shownotes How do you know when you need to work on something physical vs how do you know when to work on something emotional...
Shownotes We’ve all been there. You feel like you are doing everything but nothing seems to be working. You’ve hit a plateau or you’ve...
Shownotes Navigating a fatigue recovery experience can also come hand in hand with navigating changes in body, shape, and size. For some, this is...
